Advanced Biomed Inc.
| Metric | FY2025 | FY2024 |
|---|---|---|
| Cash | $2.9M+11.3% | $2.6M |
| Prepaid expenses and other current assets, net | $3.1M+606.0% | $443K |
| Total current assets | $6.0M+97.7% | $3.1M |
| Equipment, net | $331K-36.8% | $525K |
| Right-of-use assets, net | $65K-48.4% | $127K |
| Intangible assets, net | $119K | — |
| Deferred initial public offering (“IPO”) costs | $639K | — |
| Other non-current assets | $83K | — |
| Total non-current assets | $480K-66.0% | $1.4M |
| TOTAL ASSETS | $6.5M+46.0% | $4.5M |
| Accounts payable, accruals, and other current liabilities (including amount due to related parties – major stockholders as of June 30, 2025 and 2024, with $172,767 and $113,812 due to related parties – related corporations, and $916,036 and $674,262 due to related corporations, respectively (1)) | $2.9M+6.9% | $2.7M |
| Lease payable - current | $36K-42.4% | $62K |
| Total current liabilities | $2.9M+5.7% | $2.7M |
| Lease payable – non-current | $6K-90.9% | $65K |
| Total non-current liabilities | $146K+125.7% | $65K |
| TOTAL LIABILITIES | $3.0M+8.5% | $2.8M |
| Common stock $0.001 par value per share; as of June 30, 2025 and 2024; 400,000,000 and 400,000,000 shares authorized; 21,640,000 and 20,000,000 shares issued and outstanding, respectively* | $21640.00+8.2% | $20000.00 |
| Additional paid-in capital | $21.3M+29.4% | $16.5M |
| Accumulated deficits | -$19.2M-20.4% | -$16.0M |
| Accumulated other comprehensive income | $1.3M+19.4% | $1.1M |
| Total stockholders’ equity | $3.5M+109.1% | $1.7M |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $6.5M+46.0% | $4.5M |
| Related corporations | ||
| Amount due to related parties – related corporations, non-current | $140K | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
No Form 4 transactions on record.
| Agency |
|---|
| Department of Defense |
Informational purposes only, not investment advice.